Haleon demerger – Talk Bio

Actionable Insights Powered by AI

GSK CEO Emma Walmsley Steps Down After 9 Years; Luke Miels to Succeed

2 weeks ago talkbio0Tagged CEO, Drug Industry, Emma Walmsley, Haleon demerger, Leadership Change, Luke Miels, SmithKline Beecham, specialty medicines, Succession planning, Transition Mutation, Vaccines

Emma Walmsley; GSK; CEO transition; Luke Miels; leadership change; pharmaceutical industry; Haleon demerger; specialty medicines; vaccines; succession planning